George L. Sing - Feb 22, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Stock symbol
REGN
Transactions as of
Feb 22, 2024
Transactions value $
-$1,940,845
Form type
4
Date filed
2/26/2024, 04:07 PM
Previous filing
Feb 12, 2024
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $413K +1K +3.8% $413.33 27.3K Feb 22, 2024 Direct
transaction REGN Common Stock Sale -$970K -1K -3.66% $970.00 26.3K Feb 22, 2024 Direct
transaction REGN Common Stock Options Exercise $413K +1K +3.8% $413.33 27.3K Feb 22, 2024 Direct
transaction REGN Common Stock Sale -$965K -1K -3.66% $965.00 26.3K Feb 22, 2024 Direct
transaction REGN Common Stock Options Exercise $413K +1K +3.8% $413.33 27.3K Feb 22, 2024 Direct
transaction REGN Common Stock Sale -$960K -1K -3.66% $960.00 26.3K Feb 22, 2024 Direct
transaction REGN Common Stock Options Exercise $207K +500 +1.9% $413.33 26.8K Feb 23, 2024 Direct
transaction REGN Common Stock Sale -$493K -500 -1.86% $985.00 26.3K Feb 23, 2024 Direct
holding REGN Common Stock 750 Feb 22, 2024 by Spouse
holding REGN Common Stock 400 Feb 22, 2024 by Spouse/Cust Son
holding REGN Common Stock 1K Feb 22, 2024 by Trust for Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3K -30.49% $0.00 6.84K Feb 22, 2024 Common Stock 3K $413.33 Direct F1
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -500 -7.31% $0.00 6.34K Feb 23, 2024 Common Stock 500 $413.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.